These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9698096)

  • 1. Effects of L-triiodothyronine and the thyromimetic L-94901 on serum lipoprotein levels and hepatic low-density lipoprotein receptor, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and apo A-I gene expression.
    Ness GC; Lopez D; Chambers CM; Newsome WP; Cornelius P; Long CA; Harwood HJ
    Biochem Pharmacol; 1998 Jul; 56(1):121-9. PubMed ID: 9698096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption.
    Ness GC; Holland RC; Lopez D
    Exp Biol Med (Maywood); 2006 May; 231(5):559-65. PubMed ID: 16636304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of thyroid hormone on hepatic cholesterol 7 alpha hydroxylase, LDL receptor, HMG-CoA reductase, farnesyl pyrophosphate synthetase and apolipoprotein A-I mRNA levels in hypophysectomized rats.
    Ness GC; Pendleton LC; Li YC; Chiang JY
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1150-6. PubMed ID: 2123100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC; Zhao Z; Lopez D
    Arch Biochem Biophys; 1996 Jan; 325(2):242-8. PubMed ID: 8561503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a farnesoid X receptor antagonist on hepatic lipid metabolism in primates.
    Amano Y; Shimada M; Miura S; Adachi R; Tozawa R
    Eur J Pharmacol; 2014 Jan; 723():108-15. PubMed ID: 24361308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors.
    Bisgaier CL; Essenburg AD; Auerbach BJ; Pape ME; Sekerke CS; Gee A; Wölle S; Newton RS
    J Lipid Res; 1997 Dec; 38(12):2502-15. PubMed ID: 9458274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hepatic sterol metabolism in the rat. Parallel regulation of activity and mRNA for 7 alpha-hydroxylase but not 3-hydroxy-3-methylglutaryl-coenzyme A reductase or low density lipoprotein receptor.
    Spady DK; Cuthbert JA
    J Biol Chem; 1992 Mar; 267(8):5584-91. PubMed ID: 1544932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early diet influences hepatic hydroxymethyl glutaryl coenzyme A reductase and 7alpha-hydroxylase mRNA but not low-density lipoprotein receptor mRNA during development.
    Devlin AM; Innis SM; Shukin R; Rioux MF
    Metabolism; 1998 Jan; 47(1):20-6. PubMed ID: 9440472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 15-oxa-32-vinyl-lanost-8-ene-3 beta,32 diol on the expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and low density lipoprotein receptor in rat liver.
    Ness GC; Lopez D; Chambers CM; Zhao Z; Beach DL; Ko SS; Trzaskos JM
    Arch Biochem Biophys; 1998 Sep; 357(2):259-64. PubMed ID: 9735166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased messenger RNA levels for low-density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat liver after long-term ethanol ingestion.
    Seitz HK; Kuhn B; von Hodenberg E; Fiehn W; Conradt C; Simanowski UA
    Hepatology; 1994 Aug; 20(2):487-93. PubMed ID: 8045509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of a novel thyromimetic on lipoprotein metabolism.
    Taylor AH; Stephan ZF; Steele RE; Wong NC
    Mol Pharmacol; 1997 Sep; 52(3):542-7. PubMed ID: 9281617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic cholesterol and bile acid synthesis, low-density lipoprotein receptor function, and plasma and fecal sterol levels in mice: effects of apolipoprotein E deficiency and probucol or phytosterol treatment.
    Moghadasian MH; Nguyen LB; Shefer S; Salen G; Batta AK; Frohlich JJ
    Metabolism; 2001 Jun; 50(6):708-14. PubMed ID: 11398149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.
    Bennett AJ; Billett MA; Salter AM; Mangiapane EH; Bruce JS; Anderton KL; Marenah CB; Lawson N; White DA
    Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):167-73. PubMed ID: 7575449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
    Vaziri ND; Liang K; Azad H
    J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
    Lopez D; Ness GC
    Arch Biochem Biophys; 1997 Aug; 344(1):215-9. PubMed ID: 9244400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.
    Feingold KR; Hardardottir I; Memon R; Krul EJ; Moser AH; Taylor JM; Grunfeld C
    J Lipid Res; 1993 Dec; 34(12):2147-58. PubMed ID: 8301233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and messenger ribonucleic acid, biliary lipid secretion, and hepatic cholesterol content in methimazole-treated hypothyroid and hypophysectomized rats after triiodothyronine administration: possible linkage of cholesterol synthesis to biliary secretion.
    Day R; Gebhard RL; Schwartz HL; Strait KA; Duane WC; Stone BG; Oppenheimer JH
    Endocrinology; 1989 Jul; 125(1):459-68. PubMed ID: 2737158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels by L-triiodothyronine.
    Sample CE; Pendleton LC; Ness GC
    Biochemistry; 1987 Feb; 26(3):727-31. PubMed ID: 3567145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
    Liang K; Kim CH; Vaziri ND
    Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.